(Q34984125)

5 August 2017

1 reference

title

Hepatitis C and human immunodeficiency virus infection (English)

1 reference

5 August 2017

1 reference

David L Thomas

1

1 reference

PubMed ID

12407595

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

5 Suppl 1

1 reference

5 August 2017

S201-9

1 reference

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

5 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C virus infection in sexually active homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Protection against persistence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Determinants of the quantity of hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

The natural history of chronic hepatitis C in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

The progression of HCV-associated liver disease in a cohort of haemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C and progression of HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C virus: detection of intracellular virus particles by electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Human immunodeficiency virus infection, anemia, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Ribavirin antagonizes the effect of azidothymidine on HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Solid organ transplantation in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Correlates of hepatitis C virus infections among injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Transfusion-associated hepatitis and AIDS. What is the risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

Serological pattern ?anti-HBc alone?: Report on a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36380

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36380

1 reference

5 August 2017

1 reference

PubMed ID

12407595